Sebastien Morin

2100 Cunard Street
Laval, H7S2G5, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs.

Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs.

Journal: ACS medicinal chemistry letters

Published: May 11, 2016

Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus.

Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus.

Journal: ACS medicinal chemistry letters

Published: February 11, 2016

Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV.

Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV.

Journal: ACS medicinal chemistry letters

Published: March 15, 2014

Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.

Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.

Journal: ACS medicinal chemistry letters

Published: January 03, 2014

Identification of potent and orally bioavailable nucleotide competing reverse transcriptase inhibitors: in vitro and in vivo optimization of a series of benzofurano[3,2-d]pyrimidin-2-one derived inhibitors.

Identification of potent and orally bioavailable nucleotide competing reverse transcriptase inhibitors: in vitro and in vivo optimization of a series of benzofurano[3,2-d]pyrimidin-2-one derived inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: March 11, 2013

Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.

Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.

Journal: Bioorganic & medicinal chemistry letters

Published: February 08, 2013

Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification.

Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification.

Journal: Bioorganic & medicinal chemistry letters

Published: February 08, 2013

Identification of benzofurano[3,2-d]pyrimidin-2-ones, a new series of HIV-1 nucleotide-competing reverse transcriptase inhibitors.

Identification of benzofurano[3,2-d]pyrimidin-2-ones, a new series of HIV-1 nucleotide-competing reverse transcriptase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: December 19, 2012

Nucleotide competing reverse transcriptase inhibitors: discovery of a series of non-basic benzofurano[3,2-d]pyrimidin-2-one derived inhibitors.

Nucleotide competing reverse transcriptase inhibitors: discovery of a series of non-basic benzofurano[3,2-d]pyrimidin-2-one derived inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: December 17, 2012

Conservation of flexible residue clusters among structural and functional enzyme homologues.

Conservation of flexible residue clusters among structural and functional enzyme homologues.

Journal: The Journal of biological chemistry

Published: November 09, 2012

Chimeric β-lactamases: global conservation of parental function and fast time-scale dynamics with increased slow motions.

Chimeric β-lactamases: global conservation of parental function and fast time-scale dynamics with increased slow motions.

Journal: PloS one

Published: August 22, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026